News Mentions for the week of August 14, 2023
Our experts are often called upon to provide insight on current events and topics in the news. Here are some of the articles Stanford Psychiatry faculty have contributed to or been quoted in recently.
Esketamine Enhances Efficacy of Oral Antidepressants in Treating Fluctuating Depression Symptoms
Study reveals a single dose of esketamine nasal spray significantly improved depression symptoms when added to existing treatment. Alan Schatzberg, Kenneth T. Norris, Jr. professor of psychiatry and behavioral sciences, and Smita Das, clinical associate professor of psychiatry and behavioral sciences, are quoted.
- Scope Blog - Stanford Medicine
Bringing addiction treatment 'inside the house of medicine'
Addiction expert Keith Humphreys, the Esther Ting Memorial professor of psychiatry and behavioral sciences, discusses how to change the opioid narrative and treat the condition like a chronic disease.
Climate anxiety is normal but it should lead to action, says mental health expert
Britt Wray, instructor of psychiatry and behavioral sciences, says research shows that young people are among the most affected by climate anxiety. She offers tips on how to deal with climate anxiety in this interview.
Caring for people with fentanyl addiction often means treating terrible wounds
The Centers for Disease Control and Prevention found that xylazine was involved in 11% of opioid overdoses in the Northeast from 2019 to 2022. The Biden administration has designated the drug as an emerging threat. Keith Humphreys, the Esther Ting Memorial professor of psychiatry and behavioral sciences, provides comment.